# Aspirin in Patients With Myocardial Infarction and Thrombocytopenia

> **NCT00501345** · PHASE3 · TERMINATED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 5 (actual)

## Conditions studied

- Thrombocytopenia
- Myocardial Infarction

## Interventions

- **DRUG:** Aspirin

## Key facts

- **NCT ID:** NCT00501345
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2002-02
- **Primary completion:** 2008-02
- **Final completion:** 2008-02
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** Low accrual, study terminated.
- **Last updated:** 2012-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00501345

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00501345, "Aspirin in Patients With Myocardial Infarction and Thrombocytopenia". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00501345. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*